3i invests in newly-formed ten23 to build biologics-focused CDMO

Using the playbook that guided 3i's formation of bioprocessing platform SaniSure, the firm believes the best way to achieve its latest vision is by building it.

1 September 2021•3 mins read
Great Point Partners, Clinical Supplies Management, healthcare, clinical trial, private equity, merger, m&a
LinkedInXEmail
LinkedInXEmail

Related articles